Description
| Product Name | CAT.No | Details |
| PKU | BXC0810A | 200T |
Product Description
The Biorex Diagnostics Neonatal PKU (Phenylketonuria) Test is a high-quality neonatal screening assay developed for the early detection of phenylketonuria (PKU) in newborns. Simple, reliable, and highly sensitive, this test is ideal for clinical laboratories, hospitals, and newborn screening programmes to ensure timely diagnosis and dietary intervention.
Key Features
• Newborn-focused – compatible with heel-prick dried blood spots for minimally invasive sampling
• Quantitative measurement – accurately detects elevated phenylalanine levels indicating PKU
• Rapid and reliable results – enables prompt identification of at-risk infants
• High sensitivity and specificity – capable of detecting even mild elevations of phenylalanine
• User-friendly – straightforward procedures suitable for high-throughput neonatal screening
• Laboratory integration – supports LIMS connectivity for efficient data management
• Cost-effective – optimised for large-scale screening programmes and national initiatives
The Biorex Diagnostics Neonatal PKU Test provides a trusted, efficient, and clinically relevant solution for the early detection of phenylketonuria. Its combination of accuracy, reliability, and simplicity supports early intervention, optimised laboratory workflow, and improved long-term health outcomes for affected infants.